Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15(1):10–17.
Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences. Am J Surg Pathol 2007;31(7):979–87., , , et al.
The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system: A Gynecologic Oncology Group study. Cancer 1995;75:81–6., , ,
Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res 2006;66(15):7810–17., , , et al.
Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome?J Clin Oncol 2005;23(21):4609–16., , , et al.
Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol 2009;113(1):105–8., , , et al.
Endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma with a background of complex atypical hyperplasia and final hysterectomy pathology. Am J Obstet Gynecol 2010;202(3):278.e1–6., , , et al.
Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008;109(1):11–18., , , et al.
Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?Gynecol Oncol 2009;113(2):163–9., , , et al.
A nomogram for predicting overall survival of women with endometrial cancer following primary therapy: toward improving individualized cancer care. Gynecol Oncol 2010;116(3):399–403., , , et al.
Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol 2007;31(7):988–98., ,
Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009;105(2):103–4.
Difficulties in assessing the depth of myometrial invasion in endometrial carcinoma. Int J Gynecol Pathol 2007;26(2):115–23., ,
Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance. Int J Gynecol Pathol 2003;22(4):324–33., ,
Diffusely infiltrative endometrial adenocarcinoma – an adenoma malignum pattern of myoinvasion. Am J Surg Pathol 1999;23(1):69–78.,
Vascular “pseudo invasion” in laparoscopic hysterectomy specimens: a diagnostic pitfall. Am J Surg Pathol 2008;32(4):560–5., , ,
Vascular pseudoinvasion in laparoscopic hysterectomy specimens for endometrial carcinoma: a grossing artifact?Am J Surg Pathol 2009;33(2):298–303., , , ,
FIGO staging of endometrial adenocarcinoma: a critical review and proposal. Int J Gynecol Pathol 2009;28(1):1–9.
Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion. Gynecol Oncol 2009;113(3):316–23., , , ,
Significant variation in the assessment of cervical involvement in endometrial carcinoma: an interobserver variation study. Am J Surg Pathol 2011;35(2):289–94., , , et al.
Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion. Am J Surg Pathol 2003;27(8):1080–8., ,
Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol 2005;106(4):693–9., , , et al.
Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review. Gynecol Oncol 2007;104(3):757–60., , , et al.
Endometrial adenocarcinoma associated with subtle lymph-vascular space invasion and lymph node metastasis: a histologic pattern mimicking intravascular and sinusoidal histiocytes. Int J Gynecol Pathol 2005;24(1):73–8., ,
The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma – evidence of distinct molecular genetic pathways. Cancer 2000;88(4):814–24., , , ,
Distinctive p53 and mdm2 immunohistochemical expression profiles suggest different pathogenetic pathways in poorly differentiated endometrial carcinoma. Int J Gynecol Pathol 1998;17:129–34., , ,
Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis. Mod Pathol 2006;19(8):1091–100., , , , ,
Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 1982;49:2547–59.,
Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma: a diagnostic test for myoinvasion. Am J Surg Pathol 1995;19:371–406., , ,
Atypical polypoid adenomyoma of the uterus. A report of 27 cases. Am J Clin Pathol 1986;86:139–45., ,
Atypical polypoid adenomyofibromas (atypical polypoid adenomyomas) of the uterus – a clinicopathologic study of 55 cases. Am J Surg Pathol 1996;20:1–20., , ,
Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type. Am J Surg Pathol 2007;31(8):1203–8.,
Undifferentiated carcinoma of the endometrium and ovary: a clinicopathologic correlation. Mod Pathol 2009;22(1):238A., , ,
Undifferentiated carcinoma of the endometrium. Am J Surg Pathol 2005;29(10):1316–21., , , et al.
Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?Int J Gynecol Pathol 2006;25(1):52–8., , ,
Prognostic features of surgical stage I uterine carcinosarcoma. Am J Surg Pathol 2007;31(11):1653–61., , , ,
Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms. Am J Surg Pathol 2005;29(2):157–66., ,
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene 2001;20(1):48–57., , , et al.